Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of REEV SENSE Biomarkers Precision for Gait Analysis in Subjects With Post-stroke Gait Impairment

NCT06234878 is registered in ClinicalTrials.gov with REEV LLC as lead sponsor.

NCT NCT06234878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06234878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of REEV SENSE Biomarkers Precision for Gait Analysis in Subjects With Post-stroke Gait Impairment
Lead sponsor
REEV LLC
Phase
Not applicable
Overall status
Completed
Start date
January 8, 2024
Completion date
April 1, 2025
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gait disorders, neurologic, stroke